Current Report Filing (8-k)
March 06 2020 - 6:03AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): March 4, 2020
Kiwa
Bio-Tech Products Group Corporation
(Exact
Name of Registrant as Specified in Charter)
Nevada
|
|
000-33167
|
|
77-0632186
|
(State
or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
3200
Guasti Road, Suite 100
Ontario, CA
|
|
91761
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (626) 715-5855
(Former
name or former address, if changed since last report)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol
|
|
Name
of exchange on which registered
|
Common
Stock par value $0.001
|
|
KWBT
|
|
OTCQB
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c)
|
Item
5.02. Departure of Directors; Appointment of Directors.
On
March 4, 2020, Yvonne Wang submitted her resignation as Chief Executive Officer, with immediate effect, however, will retainer
position as a director of Kiwa Bio-Tech Products Group Corp.
On
March 4, 2020, the Board of Directors appointed Mr. Wade Li as Chief Executive Officer of the Company with immediate effect. Mr.
Li’s biography is as follows:
Wade
Li (59)
Mr. Wade Li was one of the founders of Kiwa
Bio-Tech Products Group Corporation in 1999. Previously, he was employed by the People’s Insurance Company of China.
In 1989, he established Xinhua International Market Development Co., Ltd. and served as its President, investing in a variety
of growth industries companies of high-tech, pharmaceutical, medical, real estate and related enterprises. He has extensive experience
in corporate operation. Over the past two decades, Mr. Li has focused on China’s ecological agriculture industry, and accumulated
significant experience in the field. He has also gained high recognition in the market and related government departments in microbial
fertilizer, as well as the planning and promotion of green safe agricultural products.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
None
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated:
March 5, 2020
|
Kiwa Bio-Tech Products Group Corporation
|
|
|
|
|
/s/ Wade Li
|
|
By:
|
Wade
Li
|
|
Title:
|
Chief
Executive Officer
|
Kiwa Bio Tech Products (CE) (USOTC:KWBT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kiwa Bio Tech Products (CE) (USOTC:KWBT)
Historical Stock Chart
From Sep 2023 to Sep 2024